ArticleIJU case reports2022

Long-term survival of a patient with refractory advanced adrenocortical carcinoma after combination chemotherapy with paclitaxel and carboplatin plus mitotane.

Yuki Kobayakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.